{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:54:40Z","timestamp":1770238480934,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy, has mortality rate as low as general population, previous studies have focused on identifying high-risk of sudden cardiac death. Thus, long-term systemic impact of HCM is still unclear. We sought to investigate the association between HCM and end-stage renal disease (ESRD). This was a nationwide population-based cohort study using the National Health Insurance Service database. We investigated incident ESRD during follow-up in 10,300 adult patients with HCM (age 62.1 years, male 67.3%) and 51,500 age-, sex-matched controls. During follow-up (median 2.8 years), ESRD developed in 197 subjects; 111 (1.08%) in the HCM, and 86 (0.17%) in the non-HCM (incidence rate 4.14 vs. 0.60 per 1,000 person-years, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In the HCM, the incidence rate for ESRD gradually increased with age, but an initial peak and subsequent plateau in age-specific risk were observed. HCM was a significant predictor for ESRD (unadjusted HR 6.90, 95% CI 5.21\u20139.15, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), as comparable to hypertension and diabetes mellitus. Furthermore, after adjusting for all variables showing the association in univariate analysis, HCM itself remained a robust predictor of ESRD development (adjusted HR 3.93, 95% CI 2.82\u20135.46, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The consistent associations between HCM and ESRD were shown in almost all subgroups other than smokers and subjects with a history of stroke. Conclusively, HCM increased the risk of ESRD, regardless of known prognosticators. It provides new insight into worsening renal function in HCM, and active surveillance for renal function should be considered.<\/jats:p>","DOI":"10.1038\/s41598-019-50993-5","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T10:32:32Z","timestamp":1570703552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study"],"prefix":"10.1038","volume":"9","author":[{"given":"Heesun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-8713","authenticated-orcid":false,"given":"Jun-Bean","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4966-3924","authenticated-orcid":false,"given":"In-Chang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonyee E.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-4740","authenticated-orcid":false,"given":"Su-Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goo-Yeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-2131","authenticated-orcid":false,"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve R.","family":"Ommen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"50993_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J. & Braunwald, E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res 121, 749\u2013770, https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311059 (2017).","journal-title":"Circ Res"},{"key":"50993_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron, B. J. et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92, 785\u2013789 (1995).","journal-title":"Circulation"},{"key":"50993_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian, C., Ingles, J., Maron, M. S. & Maron, B. J. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65, 1249\u20131254, https:\/\/doi.org\/10.1016\/j.jacc.2015.01.019 (2015).","journal-title":"J Am Coll Cardiol"},{"key":"50993_CR4","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"M Authors\/Task Force","year":"2014","unstructured":"Authors\/Task Force, M. et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35, 2733\u20132779, https:\/\/doi.org\/10.1093\/eurheartj\/ehu284 (2014).","journal-title":"Eur Heart J"},{"key":"50993_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron, B. J. & Maron, M. S. Hypertrophic cardiomyopathy. Lancet 381, 242\u2013255, https:\/\/doi.org\/10.1016\/S0140-6736(12)60397-3 (2013).","journal-title":"Lancet"},{"key":"50993_CR6","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0735-1097(01)01627-8","volume":"38","author":"LM Ruilope","year":"2001","unstructured":"Ruilope, L. M., van Veldhuisen, D. J., Ritz, E. & Luscher, T. F. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38, 1782\u20131787 (2001).","journal-title":"J Am Coll Cardiol"},{"key":"50993_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","volume":"113","author":"HL Hillege","year":"2006","unstructured":"Hillege, H. L. et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113, 671\u2013678, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.580506 (2006).","journal-title":"Circulation"},{"key":"50993_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/kisup.2015.2","volume":"5","author":"AJ Collins","year":"2015","unstructured":"Collins, A. J., Foley, R. N., Gilbertson, D. T. & Chen, S. C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011) 5, 2\u20137, https:\/\/doi.org\/10.1038\/kisup.2015.2 (2015).","journal-title":"Kidney Int Suppl (2011)"},{"key":"50993_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11886-003-0050-z","volume":"5","author":"SR Laskar","year":"2003","unstructured":"Laskar, S. R. & Dries, D. L. The prognostic significance of renal dysfunction in patients with chronic systolic heart failure. Curr Cardiol Rep 5, 205\u2013210 (2003).","journal-title":"Curr Cardiol Rep"},{"key":"50993_CR10","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/j.1523-1755.2005.09801.x","volume":"68","author":"Arrigo Schieppati","year":"2005","unstructured":"Schieppati, A. & Remuzzi, G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl, S7\u2013S10, https:\/\/doi.org\/10.1111\/j.1523-1755.2005.09801.x (2005).","journal-title":"Kidney International"},{"key":"50993_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.krcp.2016.09.006","volume":"35","author":"DC Jin","year":"2016","unstructured":"Jin, D. C. et al. Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients. Kidney Res Clin Pract 35, 204\u2013211, https:\/\/doi.org\/10.1016\/j.krcp.2016.09.006 (2016).","journal-title":"Kidney Res Clin Pract"},{"key":"50993_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/kisup.2015.3","volume":"5","author":"DC Jin","year":"2015","unstructured":"Jin, D. C. Dialysis registries in the world: Korean Dialysis Registry. Kidney Int Suppl (2011) 5, 8\u201311, https:\/\/doi.org\/10.1038\/kisup.2015.3 (2015).","journal-title":"Kidney Int Suppl (2011)"},{"key":"50993_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40620-017-0380-3","volume":"30","author":"SH Kim","year":"2017","unstructured":"Kim, S. H., Jo, M. W., Go, D. S., Ryu, D. R. & Park, J. Economic burden of chronic kidney disease in Korea using national sample cohort. J Nephrol 30, 787\u2013793, https:\/\/doi.org\/10.1007\/s40620-017-0380-3 (2017).","journal-title":"J Nephrol"},{"key":"50993_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijcard.2012.01.099","volume":"156","author":"J Biermann","year":"2012","unstructured":"Biermann, J. et al. Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol 156, 323\u2013325, https:\/\/doi.org\/10.1016\/j.ijcard.2012.01.099 (2012).","journal-title":"Int J Cardiol"},{"key":"50993_CR15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1681\/ASN.2005121273","volume":"17","author":"SI Hallan","year":"2006","unstructured":"Hallan, S. I. et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17, 2275\u20132284, https:\/\/doi.org\/10.1681\/ASN.2005121273 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"50993_CR16","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember, L. M. Amyloidosis-associated kidney disease. J Am Soc Nephrol 17, 3458\u20133471, https:\/\/doi.org\/10.1681\/ASN.2006050460 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"50993_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1053\/ajkd.2001.29219","volume":"38","author":"K Iseki","year":"2001","unstructured":"Iseki, K. et al. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am J Kidney Dis 38, 1235\u20131239, https:\/\/doi.org\/10.1053\/ajkd.2001.29219 (2001).","journal-title":"Am J Kidney Dis"},{"key":"50993_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10741-012-9306-2","volume":"17","author":"JG Cleland","year":"2012","unstructured":"Cleland, J. G. et al. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev 17, 133\u2013149, https:\/\/doi.org\/10.1007\/s10741-012-9306-2 (2012).","journal-title":"Heart Fail Rev"},{"key":"50993_CR19","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright Jr.","year":"2002","unstructured":"Wright, J. T. Jr. et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288, 2421\u20132431 (2002).","journal-title":"JAMA"},{"key":"50993_CR20","first-page":"542","volume":"18","author":"A Drukker","year":"1981","unstructured":"Drukker, A., Urbach, J. & Glaser, J. Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension. Proc Eur Dial Transplant Assoc 18, 542\u2013547 (1981).","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"50993_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17818-9","volume":"7","author":"SY Wang","year":"2017","unstructured":"Wang, S. Y. et al. Risk of glomerular filtration rate decline in patients with hypertrophic cardiomyopathy and obstructive sleep apnoea. Sci Rep 7, 17399, https:\/\/doi.org\/10.1038\/s41598-017-17818-9 (2017).","journal-title":"Sci Rep"},{"key":"50993_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/JN.2010.2030","volume":"24","author":"G Cerasola","year":"2011","unstructured":"Cerasola, G., Nardi, E., Palermo, A., Mule, G. & Cottone, S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 24, 1\u201310 (2011).","journal-title":"J Nephrol"},{"key":"50993_CR23","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","volume":"35","author":"M Gori","year":"2014","unstructured":"Gori, M. et al. Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction. Eur Heart J 35, 3442\u20133451, https:\/\/doi.org\/10.1093\/eurheartj\/ehu254 (2014).","journal-title":"Eur Heart J"},{"key":"50993_CR24","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","volume":"109","author":"FA McAlister","year":"2004","unstructured":"McAlister, F. A., Ezekowitz, J., Tonelli, M. & Armstrong, P. W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109, 1004\u20131009, https:\/\/doi.org\/10.1161\/01.CIR.0000116764.53225.A9 (2004).","journal-title":"Circulation"},{"key":"50993_CR25","first-page":"320","volume":"20","author":"E Nardi","year":"2007","unstructured":"Nardi, E. et al. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Nephrol 20, 320\u2013328 (2007).","journal-title":"J Nephrol"},{"key":"50993_CR26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jacc.2007.06.018","volume":"50","author":"A Verma","year":"2007","unstructured":"Verma, A. et al. The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study. J Am Coll Cardiol 50, 1238\u20131245, https:\/\/doi.org\/10.1016\/j.jacc.2007.06.018 (2007).","journal-title":"J Am Coll Cardiol"},{"key":"50993_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/hrt.2007.126003","volume":"94","author":"JS Shah","year":"2008","unstructured":"Shah, J. S. et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 94, 1288\u20131294, https:\/\/doi.org\/10.1136\/hrt.2007.126003 (2008).","journal-title":"Heart"},{"key":"50993_CR28","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J Am Coll Cardiol 52, 1527\u20131539, https:\/\/doi.org\/10.1016\/j.jacc.2008.07.051 (2008).","journal-title":"J Am Coll Cardiol"},{"key":"50993_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.078","volume":"181","author":"Y Maekawa","year":"2015","unstructured":"Maekawa, Y. et al. Improved renal function in a patient with hypertrophic obstructive cardiomyopathy after multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation. Int J Cardiol 181, 349\u2013350, https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.078 (2015).","journal-title":"Int J Cardiol"},{"key":"50993_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/01.md.0000141097.08000.99","volume":"83","author":"N Hazanov","year":"2004","unstructured":"Hazanov, N. et al. Acute renal embolism. Forty-four cases of renal infarction in patients with atrial fibrillation. Medicine (Baltimore) 83, 292\u2013299 (2004).","journal-title":"Medicine (Baltimore)"},{"key":"50993_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.038","volume":"273","author":"YJ Choi","year":"2018","unstructured":"Choi, Y. J. et al. Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study. Int J Cardiol 273, 130\u2013135, https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.038 (2018).","journal-title":"Int J Cardiol"},{"key":"50993_CR32","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/ATVBAHA.117.309803","volume":"37","author":"MK Kim","year":"2017","unstructured":"Kim, M. K. et al. Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study. Arterioscler Thromb Vasc Biol 37, 1963\u20131970, https:\/\/doi.org\/10.1161\/ATVBAHA.117.309803 (2017).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"50993_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/ije\/dyx175","volume":"47","author":"CS Park","year":"2018","unstructured":"Park, C. S. et al. Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study. Int J Epidemiol 47, 289\u2013298, https:\/\/doi.org\/10.1093\/ije\/dyx175 (2018).","journal-title":"Int J Epidemiol"},{"key":"50993_CR34","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1093\/ije\/dyv319","volume":"46","author":"J Lee","year":"2017","unstructured":"Lee, J., Lee, J. S., Park, S. H., Shin, S. A. & Kim, K. Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol 46, e15, https:\/\/doi.org\/10.1093\/ije\/dyv319 (2017).","journal-title":"Int J Epidemiol"},{"key":"50993_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","volume":"46","author":"S Cheol Seong","year":"2017","unstructured":"Cheol Seong, S. et al. Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 46, 799\u2013800, https:\/\/doi.org\/10.1093\/ije\/dyw253 (2017).","journal-title":"Int J Epidemiol"},{"key":"50993_CR36","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey, A. S. et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67, 2089\u20132100, https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00365.x (2005).","journal-title":"Kidney Int"},{"key":"50993_CR37","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo, R. et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8, R204\u2013212, https:\/\/doi.org\/10.1186\/cc2872 (2004).","journal-title":"Crit Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50993-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:32:05Z","timestamp":1671287525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50993-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50993"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50993-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14565"}}